Competition winner aims to transform cell culture space
Jade Pellet, CSO and co-founder Alt Biotech

Company news

Competition winner aims to transform cell culture space

02 Apr, 2024

Published over 2 years ago. See the latest and most current information on Company news.

Bringing a fresh approach to the cell culture market, Alt Biotech has been chosen as a winner of the 'Integra supports start-ups’ competition, receiving 12 EVOLVE manual pipettes and $1000 worth of GRIPTIPS® pipette tips to help develop its potentially game-changing technologies.

Founded to address the issues of high costs and ethical considerations around the use of animal-based growth factors commonly used to promote cell development and proliferation, the company has developed a novel bioproduction method to produce growth factors, cytokines and hormones necessary for efficient and scalable production.

Dr Jade Pellet, CSO and co-founder of Alt Biotech, said: “Our aim is to contribute towards innovation in the cell culture space, helping to propel game-changing solutions like cell therapies and cellular agriculture into the mainstream. Our proprietary process relies on a new, more sustainable and scalable bioproduction method, combined with a microorganism that produces protein at a higher rate than E. coli alternatives.”  

“The EVOLVE manual pipettes we received from Integra have allowed us to set aside dedicated equipment for each of our development workflows, eliminating any chance of cross contamination. The multichannel units have proved to be particularly valuable, helping us to minimise repetitive tasks, increase throughput, reduce well-to-well variation and expand our experimental batch sizes.

“In addition, the ECO rack GRIPTIPS are a much more sustainable solution than the temperamental alternatives we were previously using, simply snapping into place and putting an end to the constant inconvenience of poorly fitting tips. Winning the ‘Integra supports start-ups’ competition has given our workflows a much-needed efficiency boost, allowing us to streamline the development processes that will ultimately provide the cell culture industry with affordable growth factors, cytokines and hormones,“ Dr Pellet added.

More information online

Latest News

ILM 51.5 July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Exhibitor registration opens for 2027 occupational safety and health trade fair in Düsseldorf
Explore more Arrow
Pollution Solutions Online
Energy efficiency first: Why shipping must act now while low-GHG fuels scale
Explore more Arrow
Petro Online
UK refining capacity falls to four plants after a second unplanned closure
Explore more Arrow
Chromatography Today
SLAS Technology Volume 38 highlights AI-driven laboratory automation, transcriptomics and gene therapy
Explore more Arrow